Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in Children and Adolescents with Heterozygous Familial Hypercholesterolemia
NCT00827606Phase 3Completed
- Sponsor
- Viatris
- Start
- Mar 2009
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 3 trial of atorvastatin in heterozygous familial hypercholesterolemia (HeFH), sponsored by Viatris. Started Mar 2009; status: completed.
02
Drugs
atorvastatin
03
Conditions
heterozygous familial hypercholesterolemia (HeFH)
Beyond the preview
Go deeper on NCT00827606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00827606.